Targeted Inactivation of p12Cdk2ap1, CDK2 Associating Protein 1, Leads to Early Embryonic Lethality by Kim, Yong et al.
Targeted Inactivation of p12
Cdk2ap1, CDK2 Associating
Protein 1, Leads to Early Embryonic Lethality
Yong Kim
1,2*, Jim McBride
1, Lauren Kimlin
1, Eung-Kwon Pae
6, Amit Deshpande
1, David T. Wong
1,2,3,4,5*
1Division of Oral Biology and Medicine, Dental Research Institute, School of Dentistry, University of California Los Angeles, Los Angeles, California, United States of
America, 2UCLA’s Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California, United States of America, 3Molecular Biology
Institute, University of California Los Angeles, Los Angeles, California, United States of America, 4Division of Head and Neck Surgery/Otolaryngology, University of
California Los Angeles, Los Angeles, California, United States of America, 5Henry Samueli School of Engineering, University of California Los Angeles, Los Angeles,
California, United States of America, 6Section of Orthodontics, School of Dentistry, University of California Los Angeles, Los Angeles, California, United States of America
Abstract
Targeted disruption of murine Cdk2ap1, an inhibitor of CDK2 function and hence G1/S transition, results in the embryonic
lethality with a high penetration rate. Detailed timed pregnancy analysis of embryos showed that the lethality occurred
between embryonic day 3.5 pc and 5.5 pc, a period of implantation and early development of implanted embryos. Two
homozygous knockout mice that survived to term showed identical craniofacial defect, including a short snout and a round
forehead. Examination of craniofacial morphology by measuring Snout Length (SL) vs. Face Width (FW) showed that the
Cdk2ap1
+/2 mice were born with a reduced SL/FW ratio compared to the Cdk2ap1
+/+ and the reduction was more
pronounced in Cdk2ap1
2/2 mice. A transgenic rescue of the lethality was attempted by crossing Cdk2ap1
+/2 animals with
K14-Cdk2ap1 transgenic mice. Resulting Cdk2ap1
+/2:K14-Cdk2ap1 transgenic mice showed an improved incidence of full term
animals (16.7% from 0.5%) on a Cdk2ap1
2/2 background. Transgenic expression of Cdk2ap1 in Cdk2ap1
2/2:K14-Cdk2ap1
animals restored SL/FW ratio to the level of Cdk2ap1
+/2:K14-Cdk2ap1 mice, but not to that of the Cdk2ap1
+/+:K14-Cdk2ap1 mice.
Teratoma formation analysis using mESCs showed an abrogated in vivo pluripotency of Cdk2ap1
2/2 mESCs towards a
restricted mesoderm lineage specification. This study demonstrates that Cdk2ap1 plays an essential role in the early stage of
embryogenesis and has a potential role during craniofacial morphogenesis.
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Introduction
CDK2AP1 was initially identified as a cancer-related gene by
using hamster oral cancer model [1]. CDK2AP1 is a highly
conserved and ubiquitously expressed gene located on human
chromosome 12q24 and is a 115-aa nuclear polypeptide that is
downregulated in ,70% of oral cancers [2,3]. Murine Cdk2ap1
with only three amino acid deviations from the human CDK2AP1
is located at chromosome 5 [4,5]. We have obtained significant
amount of data demonstrating potential cellular function of
CDK2AP1 in vitro and in vivo [5,6,7,8,9,10,11]. In addition to its
role as a cell cycle regulatory molecule through two important
cellular partners: CDK2 and DNA polymerase-alpha/primase, we
have shown that CDK2AP1 has a role in TGF-b induced growth
arrest, cisplatin induced genotoxicity, and cellular apoptosis
[6,7,8,10,11]. Recently, we have shown the in vivo tumor regression
effect of CDK2AP1 with reducing proliferation and increasing
apoptotic indices in a xenograft mouse model of head and neck
cancer [10]. Furthermore, we have demonstrated that overex-
pression of Cdk2ap1 in a transgenic mouse model resulted in
gonadal atrophy, seminiferous tubule degeneration, and folliculo-
genesis abnormalities in vivo [12]. Despite the exact in vivo
physiological role of Cdk2ap1 remains to be determined, there
are several indirect evidences that implicate its role in develop-
ment. Cdk2ap1 has been identified as one of stem cell specific genes
that are enriched in both embryonic and adult stem cells [13].
More interestingly, it has been reported through microarray
analysis that Cdk2ap1 has been categorized as one of genes that are
expressed in an early stage preimplantation embryos and its
expression gradually decreases as the embryo further develops
[14]. Through a global expression map of cell cycle regulators in
mitosis and meiosis, Cdk2ap1 was found as one of genes with
postnatal testis maturation-associated decrease [15]. In addition,
Cdk2ap1 mRNA has been found to be elevated upon estrogen
treatment during early implantation process, suggesting its role in
uterine decidualization where the cells stop proliferation and start
differentiation [16].
Proper development of organisms including vertebrates requires
spatial and temporal orchestration between many different
molecules. Uncontrolled or deleted expression of certain gene
can cause abnormal embryo development leading to lethality
[17,18,19,20,21]. These are classes of molecules that are known to
play essential roles during development. However though their
associated molecular mechanisms have been extensively studied,
our understanding towards developmental process especially
during the early embryogenesis remains largely elusive. Early
stage of the embryo development is defined as a period of rapid
cellular proliferation to suffice the needed number of cells in a
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reduced activity of cell cycle regulatory pathways observed in
embryonic stem cells [22,23,24,25]. Several well-known cell cycle
regulatory molecules including pRb are known to remain inactive
during early gestation period until embryonic stem cells start to
differentiate into specified cell lineages [26,27,28]. The physiolog-
ical function of a given molecule or its significance in development
in vivo can be studied by taking a knockout approach in mouse. In
this paper, we examined the developmental role of Cdk2ap1
through a knockout approach via a specific deletion of Cdk2ap1 in
mouse to understand physiological significance of Cdk2ap1 during
development. Our data clearly demonstrate that Cdk2ap1 is an
essential gene during early embryo development since the targeted
homozygous disruption of Cdk2ap1 resulted in the lethality of the
early embryos. Interestingly, significant craniofacial abnormality
was observed in the Cdk2ap1 knockout model, implicating its
potential role of Cdk2ap1 in skeletal morphogenesis.
Materials and Methods
Targeted disruption of p12
Cdk2ap1 and generation of
knockout mice
Murine embryonic stem cells (ES-LW1) were grown on a gelatin
coated plate and maintained in DMEM supplemented with 15%
FBS, 0.1 mM b-mercaptoethanol, 1% L-Glutamine, 0.2% (v/v)
LIF, 1% (v/v) PSF, and 0.1% (v/v) gentamycin sulfate.
Generation of Cdk2ap1 knockout mESCs was described by Kim
et al. [5]. Established two Cdk2ap1
+/2 cells were independently
injected into blastocysts from C57/BL6. Chimeric animals were
identified by genotyping and Southern analysis and populated to
establish Cdk2ap1
+/2 mouse line. All the animals were maintained
and taken care of under the husbandry guidelines supervised by
the UCLA Chancellor’s Animal Research Committee.
Genotyping and Southern analysis of Cdk2ap1 knockout
mice
Tail biopsies from weaned animals were collected according to
the guidelines from UCLA Animal Research Committee.
Genomic DNA was extracted by incubating in 17 mM Tris-HCl
(pH 7.5), 17 mM EDTA, 170 mM NaCl, 0.85% SDS, and
0.2 mg/ml proteinase K overnight at 55uC. Final DNA pellet
was dissolved in TE and subjected to a multiplex PCR analysis by
using Advantage 2 PCR kit (Clontech, Palo Alto, CA). Primer set 1
[CDU2 (59GCCTTCTTGACGAGTTCTTCTGAG39) and
CDD2 (59TGGATGTGGAATGTGTGCGAG39)] amplifies a
460 bp fragment within the cytosine deaminase gene in the
targeting vector and primer set 2 [I2U (59ATGGGGATG-
GATGTGTGAGAGG39) and I2D (59TGGGTTCAAG-
GAAGTGGACTAATG39)] generates a 239 bp fragment from
intron 2 which is absent in a successful homologous recombina-
tion). For Southern analysis, 5 mg of DNA was digested with
Bsu36I resulting in 8.4 and 5.6 kb fragments.
Timed pregnancy analysis and genotyping
For timed pregnancy analysis, heterozygous females were mated
with heterozygous males with or without hormonal stimulation. At
day 2.5 or 3.5 dpc, females were sacrificed and the embryos were
flushed out of the uterus. Genomic DNA was isolated by using
blastocyst lysis buffer (10 mM Tris-HCl, pH 8.5, 50 mM KCl,
2 mM MgCl2, 0.45% NP-40, 0.45% Tween 20, 60 mg/ml
proteinase K) and subjected to multiplex PCR analysis with or
without genomic DNA amplification by using GenomiPhi DNA
Amplification kit (GE Healthcare, Piscataway, NJ) according to
the manufacturer’s instruction. For later gestation time points, the
embryos were fixed in 4% paraformaldehyde, rinsed under tap
water, stored in 70% EtOH and paraffin-embedded for sectioning
onto metal LCM slides. LCM slides were deparaffinized 5 min in
xylene and rehydrated in 100% EtOH for 2 min, 95% EtOH for
2 min, 70% EtOH for 2 min, 50% EtOH for 2 min and dH2O for
2 min. Slides were stained with methyl green for 30 sec and
washed in dH2O for 1–5 min. Finally slides were air dried and a
portion of embryo was microdissected into PCR caps containing
20 ml of digestion buffer (Arcturus DNA Extraction Kit). Tissue
was digested overnight as suggested by Arcturus protocol. A 5 ml
of digest was used per PCR reaction by using Advantage 2 PCR
kit (Clontech, Palo Alto, CA). Two different sets of primers were
used for genotyping analysis: For homologous recombinant DNA,
CD3F (TGTCGTATCCCAACGGTGAAGC) and CD1R
(CCAGGGCGAAGGTTTTATGC) or CD3F and CD3R
(ACATCATCGTGACCAAAGCAGACG) were used. For the
wild type DNA, Int4F (TTGCTTTGCTTGTTTCCTGGGC)
and IntR (GGCTGGGGTTTGGCTCATAGAATC) were used.
Generation of Cdk2ap1
2/2:K14-Cdk2ap1 hybrid animals
Transgenic K14-Cdk2ap1 mice were generated as described
previously [12]. Heterozygous Cdk2ap1
+/2 mice were mated
with K14-Cdk2ap1 mice and pups were analyzed by PCR
based genotyping on tail biopsies. Confirmed heterozygous
Cdk2ap1
+/2:K14-Cdk2ap1 mice were intercrossed to examine the
viability of homozygous Cdk2ap1
2/2:K14-Cdk2ap1. In addition, the
expression of transgenic Cdk2ap1 was confirmed by RT-PCR
analysis with total RNA from ear-snips. Briefly, frozen earsnips
were powdered and mixed with lysis buffer. Total RNA was
purified by using RNeasy mini kit from Qiagen (Valencia, CA).
For RT-PCR analysis, equal amount of total RNA was subjected
to reverse transcription by using Superscript III RT and oligo(dT)
primer. The synthesized cDNA was amplified by using a pair of
primers specific to mouse Cdk2ap1. In addition, GAPDH primer
was used for normalization.
Blastocyst outgrowth analysis
Embryos were harvested at 3.5 dpc as described for timed
pregnancy analysis and cultured in gelatin coated 96 well plate in
blastocyst culture medium ((DMEM, 20% FBS, 2 mM glutamine,
4 mg/ml BSA, 0.1 mM b-ME, PSF). Culture was maintained for
5 days and the hatching and outgrowth of blastocyst was
photomicrographed for comparison. At the end of culture, cells
were lysed in blastocyst lysis buffer (10 mM Tris-HCl, pH 8.5,
50 mM KCl, 2 mM MgCl2, 0.45% NP-40, 0.45% Tween 20,
60 mg/ml proteinase K) for isolation of total genomic DNA.
Genotyping analysis was performed as described above.
Mesenchymal cell culture
Primary bone marrow mesenchymal cell were isolated and
established by flushing bone marrows from the tibiae, femora, and
humeri of 4 week-old animals with cold DMEM using a 27-gauge
needle. Cells were then washed with cold PBS and cultured to
confluence in a 100 mm plate in a-MEM with 10% FBS. At
confluence cells were collected for further analysis.
Results
Targeted disruption of p12
CDK2-AP1 in mice leads to early
embryonic lethality
Significant amount of data has been gathered demonstrating the
importance of Cdk2ap1 in cellular regulation in vitro and also in vivo
[5,8,9,10]. However, the normal physiological role of Cdk2ap1 has
not been fully elucidated. As a way of evaluating the importance of
Cdk2ap1 in Embryo Development
PLoS ONE | www.plosone.org 2 February 2009 | Volume 4 | Issue 2 | e4518Cdk2ap1 in the animal development and physiology, we generated
a conventional knockout mouse model. Heterozygous and homo-
zygous Cdk2ap1 knockout murine embryonic stem cells were
generated as reported previously [5]. Targeting vector was designed
torecombinewiththe introns1 and 4,resultinginthesubstitutionof
the exons 2 and 3 with neo
r and cytosine deaminase genes (Fig. 1).
Electroporated ES-LW1 cells (129sv background) were screening
for gaining of resistance to G418. Selected heterozygous Cdk2ap1
knockout cells were further screened for homozygous knockout
through mitotic crossing over event under high dose of G418
selection. The expression of Cdk2ap1 was examined by RT-PCR,
northern and western analysis. Homozygous knockout cells showed
a complete absence of Cdk2ap1 expression [5]. To generate Cdk2ap1
knockout mice, heterozygous Cdk2ap1 knockout cell line 272 or 284
was independently injected into the blastocysts from C57/B6 mice.
The injected blastocysts were transferred into the uterus of the
pseudo-pregnant mouse. Chimeras were verified by PCR analysis
on tail DNA and southern blot analysis. Chimeric animals were
mated to generate heterozygous Cdk2ap1 knockout mouse lines and
heterozygosity was verified by multiplex PCR and southern analysis
on tail biopsies (Fig. 1). We then attempted to generate homozygous
line by mating proven heterozygous pairs. From extensive breeding
and genotyping analysis, we have found the knockout of Cdk2ap1
resulted in very high penetrating rate of embryonic lethality. As
shown in Table 1, we had 2/399 (from 84 litters) homozygous
knockout mice. The genotyping result of the two survived
homozygous Cdk2ap1 knockout mice is shown in Fig. 2. To define
a window of lethality and gain insight into the role of Cdk2ap1
during embryogenesis, we have performed a detailed timed
pregnancy analysis by using heterozygous animals. The result
showed that there were 2.5 and 3.5 dpc embryos genotyped as
homozygous knockout (7/24 and 11/66, respectively), but we have
not observed any viable Cdk2ap1
2/2 embryos after 3.5 dpc. These
data suggest that the lethality occurs after 3.5 dpc blastocyst stage
and a knockout of Cdk2ap1 may have an effect on the proper
hatching of blastocyst, the implantation of embryo, or very early
differentiation of embryos.
To determine if the deletion of Cdk2ap1 has any effect on
hatching process of blastocysts, we have performed blastocyst
outgrowth analysis. Embryos at E3.5 were collected from timed
pregnancy analysis and cultured in vitro to observe hatching and
outgrowth of embryonic stem cells. At the end of observation, cells
were genotyped to match with the phenotypes. As shown in Fig. 3,
blastocysts properly hatched and outgrew regardless of the
genotype. There were no significant changes observed among
Cdk2ap1
+/+, Cdk2ap1
+/2, and Cdk2ap1
2/2 blastocysts. This result
suggests that the lethality from the deletion of Cdk2ap1 is not due to
the abrogation in the hatching process.
Rescue of lethality by crossing Cdk2ap1
+/2 with
transgenic K14-Cdk2ap1
The process of generating knockout mice involves an extensive
in vitro screening of recombinant embryonic stem cells, including
an extended period of culturing and a selection with high dose of
antibiotics. This could potentially impose the surmount level of
pressure to the cells and lead to an unwanted bias in the analysis.
Figure 1. Generation of Cdk2ap1 knockout mice. A. Targeting vector construct pTKLNCL-Cdk2ap1 was designed to knockout Cdk2ap1 exon2
and 3 by homologous recombination. Cytosine deaminase (CD) and neomycin resistance (Neo) genes were placed in to disrupt Cdk2ap1 gene in
mouse chromosome 5. B. Multiplex genotyping analysis was used to screen recombinant ES cells as described in Materials and Methods. The top
band of 460 bp is amplified from cytosine deaminase in the targeting vector and the bottom band of 239 bp is amplified from the introns of wild
type Cdk2ap1. Mouse tail DNA was also analyzed for screening of Cdk2ap1 knockout mice by multiplex PCR. C. The multiplex PCR genotyping data
was confirmed by Southern blot analysis. The wild type Cdk2ap1 showed 8.4 kb fragment, while the recombinant showed 5.6 kb fragment.
doi:10.1371/journal.pone.0004518.g001
Cdk2ap1 in Embryo Development
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using a conditional knockout model. This is currently in progress
and we have already generated heterozygous floxed Cdk2ap1
knockout mice by crossing chimeras. Meanwhile, to ensure that
the lethality we observed with homozygous Cdk2ap1 knockout mice
was due to the specific inactivation of the gene, we tried to rescue
the lethal phenotype of Cdk2ap1
2/2 mice by taking a transgenic
approach. To complement the loss of Cdk2ap1 expression in
Cdk2ap1 knockout mice, we crossed the heterozygous Cdk2ap1
knockout (Cdk2ap1
+/2) mice with the K14-Cdk2ap1 transgenic
(Cdk2ap1
+/2:K14-Cdk2ap1) mice that overexpress Cdk2ap1 by using
human keratin 14 promoter [12]. We first generated and identified
F1 hybrid mice with Cdk2ap1
+/2 genotype and K14-Cdk2ap1
transgene integrated into the genome (Cdk2ap1
+/2:K14-Cdk2ap1). As
shown in Fig. 4A, we were able to generate hybrid mice of
Cdk2ap1
2/2 genotype with K14-Cdk2ap1 transgene integrated into
the genome. The resulting heterozygous Cdk2ap1
+/2:K14-Cdk2ap1
hybrids were then intercrossed to generate homozygous Cdk2ap1
knockout with K14-Cdk2ap1 transgene (Cdk2ap1
2/2:K14-Cdk2ap1).
Table 1. Timed pregnancy analysis by Het x Het matings.
Age Litter Total Number Genotype Resorbed
+/++ /22 /2
4 weeks 56 399 137 260 2 N/A
E10.5 5 48 21 27 0 6
E7.5 5 29 12 17 0 4
E5.5 5 24 8 16 0 N/A
E3.5 9 66 21 34 11 N/A
E2.5 4 24 5 12 7 N/A
doi:10.1371/journal.pone.0004518.t001
Figure 2. Genotyping of survived homozygous Cdk2ap1
knockout mice. Two mice (M745 and F2015) were born live out of
399 pups analyzed from crossing of heterozygous Cdk2ap1 knockout
mice. A. The genotype of both animals was analyzed by multiplex PCR
on tail DNA with no DNA negative control. B. The PCR genotyping
result was also confirmed by Southern analysis. Both M745 and F2015
mice showed homozygous knockout genotype compared to WT type
(F2041) and heterozygous (F2014) animals.
doi:10.1371/journal.pone.0004518.g002
Figure 3. Blastocyst outgrowth analysis of Cdk2ap1 knockout embryos. To examine the hatching and outgrowth of Cdk2ap1
2/2 embryos,
blastocyst outgrowth analysis was performed. Heterozygous females and males were mated for timed pregnancy analysis and E3.5 blastocysts were
collected. A. Individual blastocyst was cultured in a 96 well plate for 4 days. Photomicrograph was taken every day to monitor the hatching and
outgrowth of blastocysts. B. After final recording of morphology, outgrown cells were lysed and genomic DNA was isolated for multiplex genotyping
analysis as described in Materials and Methods. The PCR products were analyzed on a 1.5% agarose gel and the genotype was matched to the
phenotype from A.
doi:10.1371/journal.pone.0004518.g003
Cdk2ap1 in Embryo Development
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of Cdk2ap1
2/2:K14-Cdk2ap1 mice in terms of survival and proper
development. The resulting weaned pups of 4 weeks of age were
analyzed by genotyping on tail biopsies. We have analyzed 36
pups from 11 litters and the transgenic rescue approach resulted in
an improved birth of homozygous Cdk2ap1 knockout mice
(Table 2). The rate of the birth of Cdk2ap1
2/2 was increased to
16.7% from 0.5%. The expected incidence of homozygous pups
should be 25% based on Mendelian genetics. Therefore, it is about
67% of the expected number, which means while the rescue was
not achieved with 100% efficiency. It still represents significantly
improved rescue of lethality. During this hybrid mating process,
we have not obtained any homozygous Cdk2ap1 knockout mice
without the integrated Cdk2ap1 transgene. This appears especially
important because we can rule out the strain dependent genetic
modifier effect with this finding. To see if the integrated transgene
through the hybrid approach is expressed in the mice, we
examined Cdk2ap1 expression in Cdk2ap1
2/2:K14-Cdk2ap1 hybrid
animals by RT-PCR analysis on total RNA isolated from ear-
snips. As shown in Fig. 4B, we detected the expression of Cdk2ap1
mRNA in Cdk2ap1
+/+ and Cdk2ap1
+/2 mice from mating of
heterozygous Cdk2ap1
+/2 mice. The Cdk2ap1
+/2:K14-Cdk2ap1 mouse
from mating of Cdk2ap1
+/2:K14-Cdk2ap1 hybrids also expressed
Cdk2ap1 mRNA. We observed that there was Cdk2ap1
mRNA expressed in Cdk2ap1
2/2:K14-Cdk2ap1 hybrids, probably
due to the expression of transgenic Cdk2ap1. As anticipated the
Cdk2ap1
2/2:K14-Cdk2ap1 mice also expressed considerable level of
Cdk2ap1 mRNA detected by RT-PCR, while Cdk2ap1
2/2 mESCs
used as a control did not show any expression of Cdk2ap1 mRNA.
These evidence confirm that the complementary expression of
Cdk2ap1 has been achieved in Cdk2ap1
2/2:K14-Cdk2ap1 hybrids.
Craniofacial abnormalities in survived Cdk2ap1
2/2 mice
One of the interesting findings was that the two homozygous
Cdk2ap1 knockout mice (M745 and F2015) born and lived
exhibited similar craniofacial defects with a noticeable short snout
and a round forehead compared to wild type (Fig. 5A). We further
reasoned that if Cdk2ap1 plays a specific role in craniofacial
development, the hybrid mice with transgenic Cdk2ap1 expression
should overcome the craniofacial abnormality observed
in Cdk2ap1
2/2 mice. As shown in Fig. 5B, the hybrid
Cdk2ap1
2/2:K14-Cdk2ap1 mice did not show much phenotypic
difference from Cdk2ap1
+/+:K14-Cdk2ap1 or Cdk2ap1
+/2:K14-Cdk2ap1
Figure 4. Genotyping and expression analysis of Cdk2ap1
2/2:K14-Cdk2ap1 hybrids. Hybrid mice were generated by crossing heterozygous
Cdk2ap1 knockout mice and K14-Cdk2ap1 transgenic mice. A. The resulting pups were genotyped to identify hybrids by using PCR. Wild type
Cdk2ap1 gene was amplified by using Int4F and IntR primers against the Cdk2ap1 intron sequence. The recombinant Cdk2ap1 was detected by using
CD3F and CD3R primers against cytosine deaminase gene. In addition, the presence of transgenic Cdk2ap1 was detected by using hK14 and
mCdk2ap1 primers against human K14 promoter and mouse Cdk2ap1 transgene. By intercrossing heterozygous Cdk2ap1
+/2:K14-Cdk2ap1 mice, we
were able to generate homozygous Cdk2ap1
2/2:K14-Cdk2ap1 mice. Mouse ESCs (Cdk2ap1
+/+, Cdk2ap1
+/2, and Cdk2ap1
2/2) and pups (WT and
heterozygous) from mating of heterozygous Cdk2ap1 knockout mice were used as controls. B. The expression of Cdk2ap1 was examined by RT-PCR
analysis on total RNA from earsnips as described in Materials and Methods. Compared to no RT or Cdk2ap1
2/2 mESC control, comparable amount of
Cdk2ap1 mRNA was detected in Cdk2ap1
2/2:K14-Cdk2ap1 mouse tissues, which showed that the expression of Cdk2ap1 was achieved from the
Cdk2ap1 transgene in the mice with Cdk2ap1
2/2 genotype.
doi:10.1371/journal.pone.0004518.g004
Table 2. Transgenic rescue result from genotyping of
Cdk2ap1
+/2:K14-Cdk2ap1 mating.
Age Litter Total Number Genotype
+/++ /22 /2
4 weeks 11 36 10 20 6
doi:10.1371/journal.pone.0004518.t002
Cdk2ap1 in Embryo Development
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performed X-ray cephalometry of the animals. We analyzed the
morphometric difference of the facial skeletons of the animals by
comparing the Snout Length vs. Face Width (SL/FW) (Fig. 5C).
As shown in the X-ray result, Cdk2ap1
2/2 animal showed a
noticeable reduction of SL/FW ratio compared to the wild type
(Table 3). The wild type Cdk2ap1
+/+ mice showed an average SL/
FW ratio of 1.72, while Cdk2ap1
2/2 mice showed an average SL/
FW ratio of 0.80, which is only 47.0% of the wild type. This clearly
shows that the survived Cdk2ap1
2/2 mice were born with a
reduced snout length compared to wild type mice. Furthermore,
we also observed the reduction of SL/FW ratio in heterozygous
Cdk2ap1 knockout mice compared to WT. The SL/FW ratio in
heterozygous Cdk2ap1 knockout mice was 1.11, which is 65.0% of
the wild type. To see if the abnormal craniofacial morphology is
specifically due to the loss of Cdk2ap1 expression, we also
examined the SL/FW ratio of Cdk2ap1
2/2:K14-Cdk2ap1 mice rescued
by the transgenic complementation of Cdk2ap1 expression with
K14-Cdk2ap1 mice. As summarized in Table 3, we observed
that the average SL/FW ratio of Cdk2ap1
2/2 hybrid mice
Figure 5. Craniofacial abnormality of survived Cdk2ap1
2/2 mice. A. The craniofacial morphology was noticeably different between wild type
(WT) and Cdk2ap1
2/2 mice. Two survived Cdk2ap1
2/2 mice (M745 and F2015) were also compared side-by-side and both mice showed similar
craniofacial abnormality compared to WT. B. The complement expression of Cdk2ap1 in Cdk2ap1
2/2 mice by transgenic approach resulted in an
increased incidence of homozygous Cdk2ap1 knockout mice. The rescued mice (Cdk2ap1
2/2:K14-Cdk2ap1) also showed the recovery of the craniofacial
deformity to the state of the heterozygous (Cdk2ap1
+/2:K14-Cdk2ap1) mice. C. The craniofacial differences between animals were analyzed by measuring
the Snout Length (SL) and Facial Width (FW) ratio measured on the X-ray films obtained in a standardized head position as indicated by the arrows.
The average ratio was depicted and compared between Cdk2ap1
+/+ and Cdk2ap1
2/2 mice, and also the hybrid animals with Cdk2ap1
+/+:K14-Cdk2ap1,
Cdk2ap1
+/2:K14-Cdk2ap1, and Cdk2ap1
2/2:K14-Cdk2ap1 genotype.
doi:10.1371/journal.pone.0004518.g005
Table 3. Snout Length (SL) and Facial Width (FW) ratio.
Mouse line Cdk2ap1
+/+ Cdk2ap1
+/2 Cdk2ap1
2/2 Cdk2ap1
+/+:K14-Cdk2ap1 Cdk2ap1
+/2:K14-Cdk2ap1 Cdk2ap1
2/2:K14-Cdk2ap1
SL/FW 1.82 1.07 0.67 1.42 1.18 1.22
1.61 1.15 0.92 1.21 1.18 0.98
1.12
Average 1.72 1.11 0.80 1.32 1.18 1.10
Vs. +/+ 1 0.65 0.47 1 0.89 0.83
doi:10.1371/journal.pone.0004518.t003
Cdk2ap1 in Embryo Development
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+/2 hybrid
mice (SL/FW=1.18) after complementation of Cdk2ap1 expres-
sion by transgenic Cdk2ap1. In both Cdk2ap1
+/2:K14-Cdk2ap1 and
Cdk2ap1
2/2:K14-Cdk2ap1 mice, the SL/FW ratio was still smaller
than Cdk2ap1
+/+:K14-Cdk2ap1 mice (89.0% and 83.0% of the
Cdk2ap1
+/+:K14-Cdk2ap1 mice, respectively). Comparison of the SL/
FW ratios from heterozygous miceand homozygous micewithout or
with transgenic complementation showed that the ratio was
improved in the hybrid animals (increased from 73% without
complementationto93%withcomplementation),whichimpliesthat
the complementary expression of Cdk2ap1 in Cdk2ap1
2/2:K14-Cdk2ap1
mice rescued the craniofacial deformity to the state of the
heterozygous Cdk2ap1
+/2:K14-Cdk2ap1 mice.
Expression of Cdk2ap1 in mesenchymal stem cells in
rescued hybrid animals
Since K14 promoter is known to be active in epithelial lineage
cells, it is necessary to demonstrate if the rescue of craniofacial
defect by transgene is through its expression in mesenchymal cells.
To address this, we have isolated mesenchymal stem and
progenitor cells from bone marrow in rescued hybrid animals.
As shown in Fig. 6, the expression of Cdk2ap1 was detected in skin
tissues and mesenchymal cells from Cdk2ap1
+/+ and Cdk2ap1
+/2
mice. It was also found that the expression of transgenic Cdk2ap1
was detected in both skin tissues and mesenchymal cells from
Cdk2ap1
2/2:K14-Cdk2ap1 mice. This demonstrates that the expression
of K14-Cdk2ap1 transgene is not limited to epithelial cell lineages,
but also it is actively expressed in mesenchymal cells from bone
marrow of Cdk2ap1
2/2:K14-Cdk2ap1.
Altered in vivo pluripotency in Cdk2ap1
2/2 mESCs
Our extensive in vitro studies with Cdk2ap1
2/2 mESCs showed
that Cdk2ap1 plays a role in mESC differentiation by modulating
the expression of stem cell marker genes and also differentiation-
related genes, especially involved in trophoblast and mesoderm
differentiation (Kim et al., manuscript in review). The in vivo
pluripotency of Cdk2ap1
2/2 mESCs was examined by teratoma
formation analysis. Either Cdk2ap1
+/+ or Cdk2ap1
2/2 mESCs (0.5–
1.0610
6 cells) were transplanted into the testis of SCID mice. After
4–6 weeks, mice were euthanized and tumors were extracted for
histological analysis [29]. As shown in Fig. 7, both Cdk2ap1
+/+ and
Cdk2ap1
2/2 mESCs formed teratomas. However, there was
noticeable difference between tumors from Cdk2ap1
+/+ and
Cdk2ap1
2/2 mESCs at low magnification. Tumors from
Cdk2ap1
2/2 mESCs did not show definable differentiation
compared to tumors from Cdk2ap1
+/+ mESCs (Fig. 7A).
Cdk2ap1
+/+ mESCs showed proper differentiation and commit-
ment into three different lineages as shown in the Fig. 7B.
Interestingly, only types of tissues we observed in tumors from
Cdk2ap1
2/2 mESCs were bones and muscles, which are
mesoderm lineage tissues (Fig. 7C). This result demonstrates that
the deletion of Cdk2ap1 led to a compromised in vivo pluripotency
in mESCs. This is very intriguing finding that suggests a potential
role of Cdk2ap1 in mouse embryo development and also it
provides us an insight on a potential mechanism of the early
embryonic lethality in Cdk2ap1
2/2 mice. Taken together, this
suggests that the deletion of Cdk2ap1 could lead to an abrogated
differentiation of mESCs during early embryo development and
further result in the early embryonic lethality potentially through
defect in cellular differentiation and development.
Discussion
Data presented in this paper clearly demonstrate that Cdk2ap1 is
an essential gene in the proper development of mouse embryos. It
remains to be seen what kind of role Cdk2ap1 precisely play
during embryogenesis. We have obtained significant amount of
data supporting that the lethality is due to an abrogated
differentiation of mESCs, which is involved in placenta develop-
ment (Kim et al., manuscript in review). We also demonstrated
that a specific deletion of Cdk2ap1 leads to the aberrant
craniofacial development. This finding may be noteworthy even
though we only have two survived animals showing this phenotype
due to the high penetrance of lethality in Cdk2ap1
2/2 animal. It is
well known that the transforming growth factor-beta (TGF-b) and
Smad pathway is involved in craniofacial morphogenesis
[30,31,32,33]. We have extensive lines of evidence demonstrating
the function of Cdk2ap1 in cell cycle regulation, apoptosis, and
also growth arrest and tumor regression [5,8,9,10,34]. Interest-
ingly, we have also demonstrated that the functional involvement
of Cdk2ap1 in TGF-b induced growth arrest. It has been shown
that Cdk2ap1 is activated by TGF-b-Smad2 and mediates TGF-b
induced growth arrest in normal diploid cells and the loss of
Cdk2ap1 expression in squamous cell carcinoma is correlated with
disrupted TGF-b-Smad signaling pathway [9,11]. The role of the
TGF-b family in normal embryonic development, specifically in
development of the craniofacial region, has been well documented
[30,33]. The function of these molecules is vital to development of
the secondary palate. They regulate maxillary and palate
mesenchymal cell proliferation and extracellular matrix synthesis.
The function of this growth factor family is particularly critical in
Figure 6. Expression of K14-Cdk2ap1 in mesenchymal cells in the rescued mice. A. Expression of K14-Cdk2ap1 transgene was detected in
skin tissues from Cdk2ap1
2/2:K14-Cdk2ap1 mice. Earsnips from non-transgenic or transgenic mice (Cdk2ap1
+/+:K14-Cdk2ap1, Cdk2ap1
+/2:K14-Cdk2ap1,
Cdk2ap1
2/2:K14-Cdk2ap1) were harvested and subjected to Western analysis with anti-Cdk2ap1 antibody. The loading was confirmed by staining
with anti-tubulin antibody. B. To examine if the K14-Cdk2ap1 transgene is expressed in mesenchymal lineage cells, bone marrow was isolated from
Cdk2ap1
2/2:K14-Cdk2ap1 mice. Cultured mesenchymal stem and progenitor cells were subjected to Western analysis to examine the expression of
K14-Cdk2ap1 in Cdk2ap1
2/2:K14-Cdk2ap1 mice.
doi:10.1371/journal.pone.0004518.g006
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The cellular and phenotypic effects of TGF-b on embryonic
craniofacial tissue have been extensively examined, but the specific
genes that function as downstream mediators of TGF-b in
maxillary/palatal development are poorly defined. We have used
a transgenic approach to rescue the lethality by crossing with the
K14-Cdk2ap1 transgenic mice. It is well documented that K14
promoter is active in epithelial tissues, including skin, palate,
tongue, and ovary [35,36,37,38,39,40]. In the previous paper
demonstrating the phenotype of K14-Cdk2ap1 mice, we have
observed the overexpression of Cdk2ap1 in epithelial tissues [12].
Now the question we have is how the overexpression of Cdk2ap1
directed in epithelial tissues in K14-Cdk2ap1 mice rescued
craniofacial defects in mesenchymal origin. It is known that
epithelial cells can undergo transition to mesenchymal cells
through the process called epithelial-to-mesenchymal transition
(EMT) [41,42]. The roles of EMT have been described in
embryonic development and morphogenesis. In embryonic
development, it is known that EMT affects tissues on a global
scale, such as gastrulation and also formation of a three-layered
embryo. It has an effect on organogenesis of heart, musculoskeletal
system, and craniofacial structures such as palate [42]. It is also
known that TGF-b signaling is significantly associated with the
induction and maintenance of EMT [43,44,45]. Based on these,
we speculate that the overexpression of Cdk2ap1 in epithelial cells
in Cdk2ap1 knockout and K14-Cdk2ap1 hybrid embryo could have
an effect on the embryo development and on the craniofacial
development possibly through the EMT process.
From in vitro study using Cdk2ap1 knockout mouse embryonic
stem (mES) cells, we are beginning to unveil potential roles of
Cdk2ap1 during differentiation process (Kim et al., manuscript in
review). We have observed significantly compromised differenti-
ation potential in Cdk2ap1
2/2 mESCs and we are in the process of
detailing a mechanism that underlies the cellular and molecular
significance of Cdk2ap1 during the early embryogenesis. Even
though this is the first report demonstrating the importance of
Cdk2ap1 in the embryogenesis, other lines of evidences also
suggest the potential involvement of Cdk2ap1 in stem cell biology
and also implantation process [13,14,16]. Once our ongoing
attempt to generate an inducible conditional Cdk2ap1 knockout
mouse model is complete, we will be able to address standing
questions regarding the essential role of Cdk2ap1 in the animal
development and its underlying mechanisms.
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